null
SMILES: NCc1cccc(c1)N(CC1CC1)Cc1cccc(NC(=O)c2cc(nn2-c2cccc(CN)c2)C(F)(F)F)c1
InChI Key: InChIKey=KWKGWXUNXWXADH-UHFFFAOYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Plasma kallikrein (Homo sapiens (Human)) | BDBM416849![]() (1-(3-(Aminomethyl)phenyl)-N-(3-((3-(aminomethyl)ph...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | 25.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
BioCryst Pharmaceuticals, Inc. US Patent | Assay Description The effect of compounds of the invention on human plasma kallikrein activity was determined using the chromogenic substrates (DiaPharma Group, Inc., ... | US Patent US10329260 (2019) BindingDB Entry DOI: 10.7270/Q2R78HM5 | |||||||||||
More data for this Ligand-Target Pair |